Posted by Michael Wonder on 11 Aug 2019
Watchdog declines to back NHS cannabis treatment for epilepsy
8 August 2019 - NICE draft guidance and NHS England review highlight need for more research on cannabis-based medicinal products.
The fast-tracked guidance follows the re-classification of these products last year to allow specialist doctors to prescribe them where the clinical needs of patients cannot be met by licensed medicines.
The draft guidance, which is open for public consultation until 5 September 2019, considers the use of these products for people with intractable nausea and vomiting as a result of chemotherapy, chronic pain, spasticity, and severe treatment-resistant epilepsy.
